论文部分内容阅读
目的探讨88例严重胸部外伤并发胸腔感染患者的临床诊治效果。方法 88例严重胸部外伤并发胸腔感染患者,随机分为观察组及对照组,各44例。两组患者均给予常规治疗,观察组在常规治疗基础上行血必净注射液治疗。观察两组治疗结果、总结分析临床诊治有效方式。结果治疗前,两组体温(T)、呼吸频率(RR)、C反应蛋白(CRP)、白细胞(WBC)比较,差异均无统计学意义(P>0.05);治疗后,两组T、RR、CRP、WBC均明显改善,且观察组改善效果明显优于对照组,差异均具有统计学意义(P<0.05);观察组优良率97.73%(43/44)明显高于对照组的70.45%(31/44),差异具有统计学意义(P<0.05)。结论对严重胸部外伤并发胸腔感染患者使用血必净治疗,效果较好,值得临床推广使用。
Objective To investigate the clinical diagnosis and treatment of 88 cases of severe thoracic trauma complicated with chest infection. Methods 88 patients with severe thoracic trauma complicated with thoracic infection were randomly divided into observation group and control group, with 44 cases in each group. Two groups of patients were given conventional treatment, the observation group on the basis of conventional treatment of Xuebijing injection treatment. Observe the results of two groups of treatment, summarize and analyze the effective ways of clinical diagnosis and treatment. Results Before treatment, there was no significant difference in body temperature (T), respiratory rate (RR), CRP and WBC between the two groups (P> 0.05). After treatment, T, RR , CRP, WBC were significantly improved, and the observation group improved significantly better than the control group, the difference was statistically significant (P <0.05); observation group excellent and good rate of 97.73% (43/44) was significantly higher than the control group of 70.45% (31/44), the difference was statistically significant (P <0.05). Conclusion The use of Xuebijing in patients with severe thoracic trauma and chest infection is effective and is worthy of clinical application.